Clinical Study on the Effect of Elevit Pregnancy 2nd & 3rd Trimester

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Clinical Trial Summary

The aim of this study is to collect information how adding a soft gel preparation of micronutrients such as vitamins, dietary minerals plus omega-3 fatty acid (docosahexaenoic acid, DHA) to the diet of pregnant women during the 2nd and 3rd trimesters of pregnancy effects the nutritional state of the mother and infants at delivery.

See also
	Status	Clinical Trial	Phase
	Completed	`NCT02106676` - Androgen Metabolism and Reproductive Outcome	N/A
	Completed	`NCT01158976` - Effect of Omega-3 Supplementation During Pregnancy on Regulation of Stress	N/A

NCT number	NCT04438928
Study type	Interventional
Source	Bayer
Contact
Status	Completed
Phase	N/A
Start date	September 27, 2016
Completion date	December 5, 2019

Clinical Study on the Effect of Elevit Pregnancy 2nd & 3rd Trimester (Multi-micronutrients & DHA Supplement) on the Nutritional Status of Pregnant Women During Second and Third Trimester

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms